Visium Asset Management, LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 17 filers reported holding XENON PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Visium Asset Management, LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$2,936,000
-17.0%
420,000
-4.5%
0.05%
-5.7%
Q4 2015$3,538,000
-2.6%
440,0000.0%0.05%
+6.0%
Q3 2015$3,634,000
-30.0%
440,000
-2.2%
0.05%
-32.4%
Q2 2015$5,189,000
-35.2%
450,000
-5.3%
0.07%
-37.3%
Q1 2015$8,011,000
-9.9%
475,000
+5.6%
0.12%
-5.6%
Q4 2014$8,888,000450,0000.12%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders